» Articles » PMID: 18216023

Molecular Dissection of Gp130-dependent Pathways in Hepatocytes During Liver Regeneration

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2008 Jan 25
PMID 18216023
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-6 (IL-6) via its signal transducer gp130 is an important mediator of liver regeneration involved in protecting from lipopolysaccharide (LPS)-induced liver injury after partial hepatectomy (PH). Here we generated mice either defective (Delta) in hepatocyte-specific gp130-dependent Ras or STAT activation to define their role during liver regeneration. Deletion of gp130-dependent signaling had major impact on acute phase gene (APG) regulation after PH. APG expression was blocked in gp130-DeltaSTAT animals, whereas gp130-DeltaRas mice showed an enhanced APG response and stronger SOCS3 regulation correlating with delayed hepatocyte proliferation. To define the role of SOCS3 during hepatocyte proliferation, primary hepatocytes were co-stimulated with IL-6 and hepatocyte growth factor. Higher SOCS3 expression in gp130-DeltaRas hepatocytes correlated with delayed hepatocyte proliferation. Next, we tested the impact of LPS, mimicking bacterial infection, on liver regeneration. LPS and PH induced SOCS3 and APG in all animal strains and delayed cell cycle progression. Additionally, IL-6/gp130-dependent STAT3 activation in hepatocytes was essential in mediating protection and thus required for maximal proliferation. Unexpectedly, oncostatin M was most strongly induced in gp130-DeltaSTAT animals after PH/LPS-induced stress and was associated with hepatocyte proliferation in this strain. In summary, gp130-dependent STAT3 activation and concomitant SOCS3 during liver regeneration is involved in timing of DNA synthesis and protects hepatocyte proliferation during stress conditions.

Citing Articles

Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury.

Dong J, Lim W, Shekeran S, Tan J, Lim S, Goh J Int J Mol Sci. 2022; 23(13).

PMID: 35806094 PMC: 9266364. DOI: 10.3390/ijms23137089.


New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.

Giraldez M, Carneros D, Garbers C, Rose-John S, Bustos M Nat Rev Gastroenterol Hepatol. 2021; 18(11):787-803.

PMID: 34211157 DOI: 10.1038/s41575-021-00473-x.


Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib.

Sobotta S, Raue A, Huang X, Vanlier J, Junger A, Bohl S Front Physiol. 2017; 8:775.

PMID: 29062282 PMC: 5640784. DOI: 10.3389/fphys.2017.00775.


Long-term culture and expansion of primary human hepatocytes.

Levy G, Bomze D, Heinz S, Ramachandran S, Noerenberg A, Cohen M Nat Biotechnol. 2015; 33(12):1264-1271.

PMID: 26501953 DOI: 10.1038/nbt.3377.


Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells.

Chou C, Lai S, Ho C, Lin W, Chen C, Lee P PLoS One. 2015; 10(3):e0122060.

PMID: 25822713 PMC: 4379007. DOI: 10.1371/journal.pone.0122060.